Current and Future State of Arrhythmia Management Registries: Defining Endpoints and Leveraging Large Data

Description

Catheter ablation of AF is a rapidly evolving field. With the emergence of pulsed field ablation a large amount of relevant data has been generated. This session helps to explore the current state of clinical registries and the need for innovation and federated approach to creating and implementing a next-gen registry.

Learning Objectives

Describe the current state of how outcomes are defined in cardiac arrhythmia management.
Assess the relevance and performance of large clinical registries in arrhythmia disease management.
Review standardizing outcome measures and ushering novel registries leveraging AI and machine learning.

Session Chair(s)

Hugh Calkins, MD
Luigi Di Biase, MD, PhD

Presentation

Current State of Outcomes Measures and its Limitations
Presenter(s): T. Jared Bunch, MD

Real Life Performance of Arrhythmia Registries and Their Limitations
Presenter(s): Moussa Mansour, MD

EP Collaborative and Standardizing Outcomes Measures in Arrhythmia Research
Presenter(s): David S. Frankel, MD

How to Leverage Leap Frog Computing in Strengthening Clinical Registries
Presenter(s): Dhanunjaya R. Lakkireddy, MBA, MD

Disclosures

T. Jared Bunch:

Boehringer Ingelheim (Research (Contracted Grants for PIs and Named Investigators only) - Research)
Altathera (Research (Contracted Grants for PIs and Named Investigators only) - Research)
Biosense Webster, Inc. (Training for new ablation balloon - Required training for new ablation balloon to start institutional research on the device)
Pfizer, Inc. (Honoraria/Speaking/Consulting Fee - HRS committee for AF management - BMS/Pfizer Alliance and HRS Roundtable)
Abbott (Research (Contracted Grants for PIs and Named Investigators only) - Research)
Altathera (Research (Contracted Grants for PIs and Named Investigators only) - Creation of an education video based upon PEAKS registry data/study)

Moussa Mansour:

Boston Scientific (Honoraria/Speaking/Consulting Fee - Consulting)
KODEX -EPD (Stock Options – Privately Held (including start-up companies) - Consulting)
NewPace Ltd (Stock Options – Privately Held (including start-up companies) - Consulting)
Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
Medtronic,Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
Siemens (Honoraria/Speaking/Consulting Fee - Consulting)
Abbott (Honoraria/Speaking/Consulting Fee - Consulting)

David Frankel:

Abbott Medical (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
Medtronic (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Membership on Advisory Committees or Review Panels)
Huxley Biomedical (Honoraria/Speaking/Consulting Fee - Consulting)

Dhanunjaya Lakkireddy:

Medtronic,Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
AtriCure, Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
Abbott (Honoraria/Speaking/Consulting Fee - Consulting)
Biosense Webster, Inc. (Speakers' Bureau - Speaking and Teaching)

To view all Heart Rhythm 2025 Faculty Disclosures, please click here.

Summary


Availability:	No future session


Cost:	FREE


Credit Offered:	No Credit Offered

Recommended

Abstract Catalog 2025: ePosters

FREE